The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction

NCT00882466 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: human recombinant erythropoietin

Sponsor

Seoul National University Bundang Hospital